New 2-substituted 1,2,3,4-tetrahydrobenzofuro[3,2-c]pyridine having highly active and potent central alpha 2-antagonistic activity as potential antidepressants

Bioorg Med Chem Lett. 2000 Jan 3;10(1):71-4. doi: 10.1016/s0960-894x(99)00591-0.

Abstract

The synthesis and biological activity of a series of benzofuro[3,2-c]pyridines and a benzothieno[3,2-c]pyridine are described. These compounds exhibit high affinity for the alpha 2-adrenoceptor, with high selectivity versus the alpha 1-receptor. Compound 1 also shows potent in vivo central activity and has been selected for further biological and clinical evaluation.

MeSH terms

  • Adrenergic alpha-Agonists / metabolism
  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic alpha-Antagonists / chemical synthesis*
  • Adrenergic alpha-Antagonists / metabolism
  • Adrenergic alpha-Antagonists / pharmacology*
  • Animals
  • Antidepressive Agents / chemical synthesis*
  • Antidepressive Agents / metabolism
  • Antidepressive Agents / pharmacology*
  • CHO Cells
  • Clonidine / metabolism
  • Clonidine / pharmacology
  • Cricetinae
  • Humans
  • Male
  • Prazosin / metabolism
  • Prazosin / pharmacology
  • Pyridines / chemical synthesis*
  • Pyridines / metabolism
  • Pyridines / pharmacology*
  • Radioligand Assay
  • Rats
  • Receptors, Adrenergic, alpha-2 / metabolism*
  • Xylazine / metabolism
  • Xylazine / pharmacology
  • Yohimbine / metabolism
  • Yohimbine / pharmacology

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic alpha-Antagonists
  • Antidepressive Agents
  • Pyridines
  • Receptors, Adrenergic, alpha-2
  • Xylazine
  • Yohimbine
  • Clonidine
  • Prazosin